Minimum ABR Wave Voltage Amplitude for Clear Wave Identification
There is no universally defined minimum voltage amplitude threshold in clinical guidelines for determining when an ABR wave is "clear" - instead, clinical interpretation focuses on wave reproducibility, morphology, and the presence of consistent peak latencies rather than absolute amplitude values. 1
Key Principles for Wave Identification
Wave Reliability Standards
Waves I, III, and V are the constant and reproducible markers used for clinical interpretation in both adults and children, while waves II, IV, VI, and VII are variable and frequently asymmetrical or absent. 2
Wave V is the most clinically important landmark and should be clearly detectable at 60 dB peak equivalent SPL in 82% of neonates and 100% of older infants and children when using headphone technique. 3
The focus in clinical practice is on wave reproducibility across repeated trials rather than meeting a specific amplitude threshold - a wave is considered "clear" when it can be consistently identified at the same latency across multiple averaged responses. 1, 2
Amplitude Considerations and Variability
Wave amplitude alone is not a reliable measure of normality in ABR interpretation, as amplitudes show significant intra- and inter-subject variability. 2
Amplitude values are affected by multiple factors including stimulus delivery method (free field vs. headphone), with free field recordings producing higher Wave V amplitudes than headphone delivery. 3
Peak latencies and interpeak conduction times are far more clinically relevant than absolute amplitude measurements for determining hearing thresholds and identifying pathology. 2, 1
Clinical Application for Diagnostic ABR
Frequency-Specific Testing Requirements
For diagnostic ABR in infants birth to 6 months, testing should include frequency-specific ABR using air-conducted tone bursts to determine degree and configuration of hearing loss for amplification fitting. 1
Click-evoked ABR using both condensation and rarefaction stimuli is required to determine if a cochlear microphonic is present, particularly in infants with risk factors for auditory neuropathy. 1
Wave V Detection Thresholds
In neonates (gestational age 36-41 weeks), Wave V is detectable at 60 dB in 82% using headphone technique and 78% using free field technique. 3
In children older than 6 months, Wave V should be clearly detectable at 60 dB in 100% of cases with normal hearing. 3
Normal reference values for tone-burst ABR response thresholds vary by age: infants 0-12 months show higher thresholds (27.25 ± 9.47 dBnHL at 0.5 kHz) compared to children 37-48 months (18.25 ± 5.83 dBnHL at 0.5 kHz). 4
Important Clinical Caveats
Age-Related Differences
ABR waveform morphology changes with age - in the first 6 months only three waves are typically visible, while the typical 4-5 waves of adult tracings become detectable at 8-12 months of age. 3
Wave V latency values in neonates and young infants (0-6 months) are statistically different from older children, with longer latencies in younger age groups. 3, 4
Testing Conditions
Automated ABR screening uses 35 dB near hearing level clicks and provides pass/fail results without requiring amplitude interpretation. 5
For diagnostic purposes, testing across multiple intensity levels is essential, as interpeak conduction times (not amplitudes) are the primary diagnostic parameters and remain stable across different stimulus intensities. 2
Standard test-retest variability for ABR typically fluctuates by ±5 dB, so changes less than 10 dB may not represent true threshold shifts. 6